Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation
Molecular Diversity · 2025
DOI: 10.1007/s11030-024-10906-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Diversity, 2025. Verfasst von Mohammed M Ghoneim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah, 13713, Saudi Arabia. Hauptthemen laut MEDLINE: Pyrazoles, Cyclooxygenase 2 Inhibitors, Inflammation, Anti-Inflammatory Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 97 Literaturangaben.
Abstract (Originalsprache)
Pyrazole heterocycle is regarded as an extremely significant agent for the therapy of inflammation. Celecoxib, lonazolac, deracoxib, and phenylbutazone are examples of commercially approved pyrazole drugs with COX-2 inhibitory potential for curing inflammation. There have been recently many reviews for the biological significance of pyrazole derivatives. This review talks about pyrazole derivatives with anti-inflammatory activity and also sheds the light on the recent updates on pyrazole research with an emphasis on some synthetic pathways utilized to construct this privileged scaffold and structure activity relationship that accounts for the anti-inflammatory activity in an attempt to pave the opportunity for medicinal chemists to develop novel anti-inflammatory agents with better COX-2 selectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah, 13713, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, 72388, Saudi Arabia. mhdgwd@ju.edu.sa.
- Chemistry Department, College of Science, Jouf University, P.O. Box: 2014, Sakaka, Saudi Arabia.
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Beni-Suef University, 62514, Beni-Suef, Egypt. raniabakr@ymail.com.
Zitieren
APA
Ghoneim, M. M., Abdelgawad, M. A., Elkanzi, N. A. A., & Bakr, R. B. (2025). Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation. Molecular Diversity. https://doi.org/10.1007/s11030-024-10906-9
Vancouver
Ghoneim MM, Abdelgawad MA, Elkanzi NAA, Bakr RB. Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation. Molecular Diversity. 2025. doi:10.1007/s11030-024-10906-9
BibTeX
@article{Ghoneim2025,
author = {Ghoneim, Mohammed M and Abdelgawad, Mohamed A and Elkanzi, Nadia A A and Bakr, Rania B},
title = {Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-024-10906-9}
}
EUVIMED